UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 33

Sortiert nach

Efficacy and safety of alirocumab in insulin-treated patients with type 1 or type 2 diabetes and high cardiovascular risk: Rationale and design of the ODYSSEY DM–INSULIN trial

Diabetes & metabolism, 2017-10, Vol.43 (5), p.453-459

2017

Volltextzugriff (PDF)

Treatment adherence to the proprotein convertase subtilisin/kexin type 9 inhibitor alirocumab in six ODYSSEY phase 3 clinical studies with treatment duration of 52 – 104 weeks

Atherosclerosis, 2016-09, Vol.252, p.e254-e254

2016

Volltextzugriff (PDF)

Pharmacodynamic relationship between PCSK9, alirocumab, and LDL-C lowering in four phase 3 odyssey trials with/without statin background

Atherosclerosis, 2016-09, Vol.252, p.e231-e231

2016

Volltextzugriff (PDF)

Relationship between alirocumab, PCSK9 and LDL-C levels: results from the odyssey mono phase 3 trial of alirocumab 75 mg every 2 weeks

Atherosclerosis, 2014-08, Vol.235 (2), p.e34-e35

2014

Volltextzugriff (PDF)

Study of agreement between LDL size as measured by nuclear magnetic resonance and gradient gel electrophoresis

Journal of lipid research, 2004-06, Vol.45 (6), p.1069-1076

2004

Volltextzugriff (PDF)

A genome‐wide association study suggests that MAPK14 is associated with diabetic foot ulcers

British journal of dermatology (1951), 2017-12, Vol.177 (6), p.1664-1670

2017

Volltextzugriff (PDF)

A genome-wide association study suggests an association of Chr8p21.3 (GFRA2) with diabetic neuropathic pain

European journal of pain, 2015-03, Vol.19 (3), p.392-399

2015

Volltextzugriff (PDF)

Dulaglutide is cardioprotective with or without background metformin in patients with diabetes and established or high risk for coronary vascular disease. A subgroup analysis of the REWIND Trial

EUROPEAN HEART JOURNAL, 2020-11, Vol.41 (Supplement_2), p.3353

2020

Volltextzugriff (PDF)

End-stage renal disease and survival in people with diabetes: a national database linkage study

QJM : An International Journal of Medicine, 2015-02, Vol.108 (2), p.127-134

2015

Volltextzugriff (PDF)

Mortality in people with Type 2 diabetes in the UK

Diabetic medicine, 2006-05, Vol.23 (5), p.516-521

2006

Volltextzugriff (PDF)

Effect of atorvastatin on C-reactive protein and benefits for cardiovascular disease in patients with type 2 diabetes: analyses from the Collaborative Atorvastatin Diabetes Trial

Diabetologia, 2015-07, Vol.58 (7), p.1494-1502

2015

Volltextzugriff (PDF)

PARAMETERS DERIVED FROM RESERVOIR PRESSURE ANALYSIS INDEPENDENTLY PREDICT CARDIOVASCULAR EVENTS IN A MULTI-CENTRE STUDY OF INDIVIDUALS WITH TYPE 2 DIABETES

Journal of hypertension, 2018-06, Vol.36 (Supplement 1), p.e286-e287

2018

Volltextzugriff (PDF)

Lipoprotein(A) Predicts Cardiovascular Events In Statin Outcome Trials: Pooled Analysis Of Seven Randomised Controlled Trials

Atherosclerosis, 2019-08, Vol.287, p.e8-e9

2019

Volltextzugriff (PDF)

Risk of stroke in people with type 2 diabetes in the UK : a study using the General Practice Research Database

Diabetologia, 2006-12, Vol.49 (12), p.2859-2865

2006

Volltextzugriff (PDF)

Risk of myocardial infarction in men and women with type 2 diabetes in the UK: a cohort study using the General Practice Research Database

Diabetologia, 2008-09, Vol.51 (9), p.1639-1645

2008

Volltextzugriff (PDF)

A genome‐wide association study suggests an association of C hr8p21.3 ( GFRA2 ) with diabetic neuropathic pain

European journal of pain, 2015-03, Vol.19 (3), p.392-399

2015

Volltextzugriff (PDF)

SAI-4

The American journal of cardiology, 2001-07, Vol.88 (2), p.76

Colhoun, H.M.

2001

Volltextzugriff (PDF)

SAI-4: The relation of ankle-brachial pressure to coronary artery calcification in diabetes

The American journal of cardiology, 2001, Vol.88 (2), p.76-76

Colhoun, H.M.

2001

Volltextzugriff (PDF)

The effect of atorvastatin on serum lipids, lipoproteins and NMR spectroscopy defined lipoprotein subclasses in type 2 diabetic patients with ischaemic heart disease

Atherosclerosis, 2003-04, Vol.167 (2), p.243-255

2003

Volltextzugriff (PDF)

High risk of cardiovascular disease in patients with type 1 diabetes mellitus in the UK, a cohort study using the General Practice Research Database

Diabetes care, 2006, Vol.29 (4)

2006

Volltextzugriff (PDF)

All-cause mortality rates in patients with type 1 diabetes mellitus compared to a non-diabetic population from the General Practice Research Database (GPRD), 1992-1999

Diabetologia, 2006, Vol.49 (4)

2006

Volltextzugriff (PDF)

Risk of cardiovascular disease very high in patients with type 1 diabetes

Nature clinical practice cardiovascular medicine, 2006-08, Vol.3 (8), p.407-408

2006

Volltextzugriff (PDF)

A novel common variant −181 G insertion in the promoter of the gene for phospholipid transfer protein

Atherosclerosis, 2005-05, Vol.180 (1), p.211-213

2005

Volltextzugriff (PDF)

Parental history of hypertension and parental history of diabetes and microvascular complications in insulin-dependent diabetes mellitus: the EURODIAB IDDM complications study

Diabetic medicine, 1998-05, Vol.15 (5), p.418-426

1998

Volltextzugriff (PDF)

Apo E phenotype is associated with coronary artery calcification in the general population but not in type 1 diabetic patients

Atherosclerosis, 2000-07, Vol.151 (1), p.14-14

2000

Volltextzugriff (PDF)

1 – 25 von 33

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(29)
Mit Volltextzugriff
(32)

Publikationsform

Artikel
(32)
Dissertationen
(1)

Sprache

Englisch
(29)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(12)
Science & Technology
(12)
Humans
(11)
Female
(10)
Male
(10)
Diabetes Mellitus, Type 2 - Complications
(8)
Middle Aged
(8)
Adult
(7)
Aged
(7)
Diabetes
(6)
Endocrinology & Metabolism
(6)
Biological And Medical Sciences
(5)
Follow-Up
(5)
Medical Sciences
(5)
Risk Factors
(5)
Cohort Studies
(4)
Diabetes. Impaired Glucose Tolerance
(4)
Diagnosis
(4)
Endocrine Pancreas. Apud Cells
(4)
Endocrinopathies
(4)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Efficacy and safety of alirocumab in insulin-treated patients with type 1 or type 2 diabetes and high cardiovascular risk: Rationale and design of the ODYSSEY DM–INSULIN trial

Treatment adherence to the proprotein convertase subtilisin/kexin type 9 inhibitor alirocumab in six ODYSSEY phase 3 clinical studies with treatment duration of 52 – 104 weeks

Pharmacodynamic relationship between PCSK9, alirocumab, and LDL-C lowering in four phase 3 odyssey trials with/without statin background

Relationship between alirocumab, PCSK9 and LDL-C levels: results from the odyssey mono phase 3 trial of alirocumab 75 mg every 2 weeks

Study of agreement between LDL size as measured by nuclear magnetic resonance and gradient gel electrophoresis

A genome‐wide association study suggests that MAPK14 is associated with diabetic foot ulcers

A genome-wide association study suggests an association of Chr8p21.3 (GFRA2) with diabetic neuropathic pain

Dulaglutide is cardioprotective with or without background metformin in patients with diabetes and established or high risk for coronary vascular disease. A subgroup analysis of the REWIND Trial

End-stage renal disease and survival in people with diabetes: a national database linkage study

Mortality in people with Type 2 diabetes in the UK

Effect of atorvastatin on C-reactive protein and benefits for cardiovascular disease in patients with type 2 diabetes: analyses from the Collaborative Atorvastatin Diabetes Trial

PARAMETERS DERIVED FROM RESERVOIR PRESSURE ANALYSIS INDEPENDENTLY PREDICT CARDIOVASCULAR EVENTS IN A MULTI-CENTRE STUDY OF INDIVIDUALS WITH TYPE 2 DIABETES

Lipoprotein(A) Predicts Cardiovascular Events In Statin Outcome Trials: Pooled Analysis Of Seven Randomised Controlled Trials

Risk of stroke in people with type 2 diabetes in the UK : a study using the General Practice Research Database

Risk of myocardial infarction in men and women with type 2 diabetes in the UK: a cohort study using the General Practice Research Database

A genome‐wide association study suggests an association of C hr8p21.3 ( GFRA2 ) with diabetic neuropathic pain

SAI-4

SAI-4: The relation of ankle-brachial pressure to coronary artery calcification in diabetes

The effect of atorvastatin on serum lipids, lipoproteins and NMR spectroscopy defined lipoprotein subclasses in type 2 diabetic patients with ischaemic heart disease

High risk of cardiovascular disease in patients with type 1 diabetes mellitus in the UK, a cohort study using the General Practice Research Database

All-cause mortality rates in patients with type 1 diabetes mellitus compared to a non-diabetic population from the General Practice Research Database (GPRD), 1992-1999

Risk of cardiovascular disease very high in patients with type 1 diabetes

A novel common variant −181 G insertion in the promoter of the gene for phospholipid transfer protein

Parental history of hypertension and parental history of diabetes and microvascular complications in insulin-dependent diabetes mellitus: the EURODIAB IDDM complications study

Apo E phenotype is associated with coronary artery calcification in the general population but not in type 1 diabetic patients

Suchergebnisse filtern